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Detection ofAneuploidy in Human Sperm
by R. W. Kapp, Jr.*
Adequatemethodsformonitoring anytypeofgameticmutationdirectly inmanarevirtuallynonexistent.
AmethodispresentedbywhichonecanmonitorYchromosomal nondisjunctiondirectlyinthemalegamete
byquantifyingthenumberofspermatozoawithtwofluorescentbodies(YFF)in 1000spermcounted. Dried
semen slides are stained with quinacrine dihydrochloride and examined under a fluorescent microscope
with dark field illumination. This method eliminates the biopsy required for other meiotic studies and
further eliminates bias in gametogenic seection by evaluating ejaculated mature spermatozoa.
Since chromosomal numerical errors are found In 0.4% of term births and 35% ofmiscarriages, it is
evidentthatchromosomal aneuploidyconstitutes themajormutagenicloadInman. Inviewoftheincreases
observed in the incidence of YFF sperm in patients receiving antineoplastic therapy and in the DBCP-
exposed workers, it may be prudent for men who have a history of exposure to mutagens and who are
contemplating reproduction to be evaluated by this method prior to attempting conception.
Further, this procedure could also be applied to the clinical phase of new drug testing to evaluate the
effects ofthat agent with respect to aneuploidy since the increases in Ychromosomal nondisjunction may
well act as a barometer for increases in overall autosomal nondisjunction.
Introduction
Mutagenic agents can impede the flow of genetic
information by various mechanisms. Ifthese agents
effect the gametic cells, it is possible that those ga-
metes which are not selected againstmeiotically will
persistin aviableform. Shouldfertilization occurthe
outcome can end only in abortion or abnormal
offspring.
The most clinically relevant stage ofhuman muta-
tion is gametically transferred, since it becomes in-
corporated into the gene pool. Gametes are subject
to several types ofmutation. Point mutations can be
either base-pair substitutions or frameshift type
mutations. In the case ofbase-pair substitutions, the
purines convert to pyrimidines or vice versa. Ifthis
occurs in the first or second position of the triplet
code, there is a high probability that there will be an
insertion of an incorrect amino acid in that protein
sequence. In frameshift type mutations, bases are
added or deleted, resulting in a translation of the
triplet code which is "out offrame" from that point
on.
Chromosomal mutations can be either structural
or numerical. In the case of structural aberrations,
pieces ofchromosomes are broken and either added
toanother chromosome or deleted. The second type
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of chromosomal mutation is numerical. Numerical
errors are termed aneuploidy or nondisjunction and
can occur during meoisis or in the early stages of
mitosis in the zygote and represent a failure of
homologous chromosomes to separate during cell
division. Thenetresultiscellswhichpossessonetoo
few chromosomes (monosomy) or those which pos-
sess one too many chromosomes (trisomy).
Aneuploidy has a high background rate in man -
approximately 0.4% ofterm births (1) and over 35%
ofearly spontaneous abortions (2). One in every 700
term births displays the aneuploidic condition
Down's syndrome (3), whereas phenotypically ex-
pressed recessive point mutations such as Pompe's
disease are found in about only 1 in 400,000 term
births (4). Hence, Down's syndrome is about 570
times as prevalent as Pompe's disease.
Aneuploidy clearly burdens society and the
human gene pool and contributes to mutation on the
worstbiologicallevel, sincetheseindividualsdisplay
many biochemical and structural deficiencies which
are usually accompanied by severe mental retarda-
tion. Coupled with the biological problems is the
economic drain on society and the family involved
since many ofthese individuals must be maintained
in long-term health care facilities.
Based upon these data, it was decided that one of
the most clinically relevant signs of germinal mu-
tation in man is that of chromosomal aneuploidy.
27Ideally, one should examine gametic tissue from
humans for the presence of aneuploidy.
Therefore, human semen was collected and
analyzed for the presence of Y chromosomal
aneuploidy. Zech (5) and Vosa (6) noted that the
distal portion ofthe long arm ofthe Y chromosome
fluoresces brightly when stained with quinacrine di-
hydrochloride. The same phenomenon can be ob-
served in the interphase Y chromosome of human
spermatozoa as described by Barlow and Vosa (7).
Since the XYY male is also an aneuploidy condi-
tion with an incidence of I in 1000 male term births
(8), itisbelieved thatYchromosomal aneuploidyis a
relevant marker for human gametic nondisjunction.
Materials and Methods
Ejaculates were collected into a sterile siliconized
glass bottle and were immediately brought to the
laboratory. Slideswerepreparedbyplacingadropof
semen upon a slide and then pressing another slide
finnly against the first. The two slides were pulled
apart to produce a uniform film. The slides were
dried horizontally for about 24 hr. The dried semen
was fixed in absolute methanol for 15 min and sub-
sequently stained for 40 min in a solution made up
from 50 mg of quinacrine dihydrochloride (Sigma
Chemical Co., St. Louis), 50 ml oftap water, and 5
ml of ethanol. The slides were then drained and
rinsed for 30 sec in standing tap water. The slides
were mounted in Mcllvaine's buffer solution (pH
5.5) and left undisturbed until the time ofevaluation,
approximately 3 hr later (9).
All slides were coded and examined on a Nikon
Model FL-S set up for evaluation of fluorescent
material with dark field illumination (100x objective
and HBO 200 high-pressure mercury vapor lamp
with BG 12 exciter filter and No. 53 barrier filter).
Only normal spermatozoa were scored, i.e., those
unremarkable insizeandshape, intactwithcomplete
membranes, and possessing an attached tail.
Further, each fluorescent body was required to fall
within the intact membranes and it had to form a
distinct point oflight. Ideally, 1000 sperm were ex-
amined from each specimen; however, this was not
possible in some cases. A minimumof400 sperm per
sample was examined where slides were difficult to
read.
Results
As seen in Table 1, evaluation of30 semen speci-
mensfrom asingle individual (case 1)with no known
mutagenic exposure demonstrated an average YF
frequency of39.3% (range: 32.8-44.1%) and an aver-
age YFF frequency of 1.3% (range: 0.7-2.2%). The
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sampling period for case 1 was approximately 400
days. Figure 1 displays the incidence ofYFF sperm
as a function oftime. There are sporadic changes in
these YFF values; therefore, serial sampling is nec-
essary to establish a baseline. The overall back-
ground frequency for YFF sperm is 1.3% as deter-
mined from analysis of 262 semen samples (10).
Case 6 (Fig. 2) was a 22 year-old patient with
metastatic osteogenic sarcoma. He had previously
undergone a lobectomy and combined radiation-
chemotherapy treatment. Two semen samples were
collected prior to a standard three-month course of
doxorubicin hydrochloride (Adriamycin). The YFF
values for this patient showed a three to four-fold
increase approximately one month after starting
therapy. YFF values generally remained elevated
after the next five samples; however, the patient's
condition deteriorated, and further cooperation be-
came impossible.
Case 7 (Fig. 3) was a 28 year-old physician who
began fluoroscopy residency at the point indicated
by the arrow. Three to five weeks after exposure
there is a sharp increase in the frequency of YFF
sperm observed.
Table 1. YF and YFF frequencies in serial semen
samples from a nonexposed donor (case 1).
Sample No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Mean
YF, %
36.2
37.8
34.4
39.1
41.0
44.1
38.6
36.9
37.2
34.1
32.8
38.1
39.9
43.0
41.4
41.3
44.0
40.4
38.6
37.7
38.2
39.9
41.1
43.2
42.0
38.9
38.8
36.4
40.8
43.1
39.3
YFF, %
1.6
1.4
1.2
0.7
0.8
1.1
1.1
1.1
1.3
1.4
1.6
1.8
1.8
1.9
1.2
1.1
1.0
0.8
0.8
0.9
1.1
1.2
1.1
1.9
2.2
2.1
1.0
1.2
1.4
1.1
1.3
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FIGURE2. YFFfrequencyofnine serial semensamplestakenfrom
an individual being treated with Adriamycin for osteogenic
sarcoma (case 6).
Case 8 (Fig. 4) was a32-yearold research scientist
with intestinal amebiasis who underwent diagnostic
radiation 9 days before starting on a 10-day regimen
of Flagyl. YFF values for this individual revealed
a doubling five weeks post-radiation exposure.
Personal communications with A. Wyrobek of
Lawrence Livermore Laboratories, Livermore,
California, indicate that the sperm morphology ab-
normalities on these same semen specimens also
show increases at the same intervals. Further inves-
tigations are currently underway.
Figure 5 shows the incidence of YFF sperm
plotted against time in a 28 year-old individual (case
14) with a seminoma (testicular tumor). The initial
sample was collected prior to serial x-ray therapy.
Note that three to four weeks after initiation of
treatment there is a five to six-fold increase in the
incidence of YFF sperm.
Table 2 shows data from a group of 18 men who
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FIGURE 3. YFF frequency of eight serial semen samples taken
from a physician on fluoroscopy residency (case 7).
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FIGURE 4. YFF frequency of eight serial semen samples taken
from aresearchscientistexposed to x-rayradiationandFlagyl
(case 8).
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1. YFF frequency of 30 serial semen samples taken from a donor (case 1).
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FIGURE 5. YFFfrequency of 18 serial semen samples taken from an individual being treated with x-ray
therapy for seminoma (case 14).
Table 2. YF and YFF frequendes in semen samples
from DBCP-exposed worinen.
Case YF, % YFF, %
16 44.5 3.3
17 41.3 2.8
18 42.3 5.0
19 40.0 4.5
20 41.5 3.8
21 46.3 3.8
22 42.5 2.0
23 40.3 2.8
24 37.3 4.0
25 41.3 4.3
26 36.3 2.0
27 40.5 5.0
28 43.3 5.3
29 39.0 3.5
30 43.0 4.0
31 46.0 4.0
32 39.5 4.5
33 44.8 4.0
Mean 41.8 3.8
have experienced occupational exposure to dibro-
mochloropropane (DBCP). There were originally 30
semen samples collected; however, 12 of the sam-
ples were aspermic and analysis was not possible.
The 18analyzable semen samples (cases 16-33) from
DBCP-exposed workers revealed an average YF
frequency of 41.8% (range: 36.3-46.3%) which is
Table 3. Distributon of nonexposed and DBCP-exposed
individuals as a function of the
percentage of YFF spenn.
Number ofsamples with
YFF sperma
Group 0-2% > 2%
Nonexposed 43 2
individuals
DBCP-exposed 2 16
individuals
ax12 = 40.88, p < 0.001.
similar to that ofthe nonexposed individuals (Table
1). The average incidence of YFF sperm in the ex-
posed workers was 3.8% (range: 2.0-5.3%). Table 3
presents the distribution of individuals with normal
(less than 2%) (11, 12) and abnormal (greater than
2%) (13) incidence of Y chromosomal nondisjunc-
tion. As canbe seen,43 of45 nonexposedindividuals
fell within the normal range, while 16 of 18 DBCP-
exposed workers fell outside the normal range.
These differences betweenexposed and nonexposed
control individuals are statistically significant (p <
0.001) as determined by X2-analysis with one degree
offreedom.
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30Discussion
The 24, YY gamete represents a disjunctional
error in spermatogenesis in which the replicated
male chromosomes have failed to separate. Itis well
established that chromosomal numerical errors con-
stitute a significant portion ofmutation in man since
0.4% of all term births display aneuploidy (1). The
fact that the 24, YY sperm exists and constitutes a
viable gamete is evident, since the XYY individual
exists in a frequency of about 1 in 1000 male term
births (8).
Since autosomal aneuploidy has been shown to
increase with age (14) and since paternal age has
been suggested to be a factor in the incidence of
aneuploidy (15), it is possible that an increase in the
frequency of 24, YY sperm could infer a potential
increase in autosomal aneuploidy as well. Thus, this
is the rationale in utilizing this unique gametic
marker to screen at risk populations (10).
The increase in YFF sperm appears to be corre-
lated to the exposure of the individual to radiation
(cases7and 14), toAdriamycin(case6)andradiation
andFlagyl (case 8). Itispossiblethattheexposure of
theworkers to DBCP as shown inTable 2 increased
theincidence ofYFF sperm. Clearly, as agroup, the
DBCPworkers displayed a significantly elevated in-
cidence of YFF sperm when compared to the YFF
sperm in unexposed males (9).
It is believed that YFF monitoring ofsperm could
be used to detect gametic nondisjunction in the
human male. In view ofthe changes observed in the
patients receiving antineoplastic therapy and in the
DBCP-exposed workers, it may be prudent for men
whohave ahistoryofexposuretomutagens andwho
are contemplating reproduction to be evaluated for
evidence of Y chromosomal aneuploidy before at-
tempting conception. Genetic counseling coupled
with chromosomal analyses by aminiocentesis
shouldbemadeavailable tothe wivesofthese menin
the event of pregnancy.
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